Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote Monitoring

Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age18+
SponsorCentre Oscar Lambret

About this trial

This is a multicenter, interventional, randomized study among adult patients recently diagnosed with a rare tumor (\<12 months). The study will aim to compare compliance with the personalized post-treatment surveillance plan, established for each patient according to national guidelines, when the surveillance is conducted in person by a hospital-based physician (control arm) or remotely by a trained nurse (experimental arm).

Eligibility criteria

Qualifiers

Positive diagnosis (anatomopathology) of tumor within 12 months

Patient 18 years of age or older

Desmoid fibromatosis of the abdominal wall operated on or under active surveillance

Stage I testicular seminoma (whether or not treated with carboplatin AUC7)

Disqualifiers

Contraindication to imaging tests required for the surveillance plan

No telephone

Patient under guardianship or curatorship

Trial design

Treatments tested in this trial

  • Oncological Follow-up

Treatment groups

88 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Centre Oscar Lambret

Lead sponsor

Canceropôle Nord Ouest

Collaborator

Groupement Interrégional de Recherche Clinique et d'Innovation

Collaborator